Physician

D Gary Soya, M.D.

According to 2025 Medicare claims, D. Soya, M.D. (NPI: 1932175981) practices cardiology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is AMARILLO HEART INSTITUTE, LLP (NPI: 1295448710; TIN: 883862154) and primary practice location at 79124-2193. Soya is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Soya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,109 traditional Medicare patients, billed 9,762 HCPCS/CPT codes, and received $961,703 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 12,017 prescription claims across 1,385 beneficiaries totaling $778,161 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 12 claims. Open Payments data shows 23 records totaling $462. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $374,537 to $778,161. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $27,062 and ending at $14,218.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	4,320	30,714	$1,304,051
2016	4,199	32,964	$1,313,053
2017	3,980	25,458	$1,178,590
2018	4,965	27,377	$1,133,667
2019	5,382	29,190	$1,446,547
2020	3,730	24,901	$1,262,522
2021	3,356	20,244	$1,144,428
2022	3,214	17,047	$939,329
2023	3,086	13,645	$1,054,591
2024	3,109	9,762	$961,703

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,143	14,175	$374,537
2016	1,175	14,289	$363,387
2017	1,221	13,721	$382,116
2018	1,277	14,075	$448,190
2019	1,378	14,570	$565,905
2020	1,406	14,951	$636,630
2021	1,376	13,384	$733,352
2022	1,405	12,510	$696,643
2023	1,379	11,822	$744,681
2024	1,385	12,017	$778,161

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	23	234	$25,264
2016	22	240	$17,103
2017	21	223	$9,600
2018	N/R	139	$6,315
2019	N/R	46	$2,482
2020	N/R	43	$2,608
2021	N/R	32	$3,058
2022	N/R	43	$32,415
2023	N/R	12	$1,268
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,198	1,871	$83
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	514	520	$82
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	473	475	$49
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,185	1,487	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	909	1,248	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	358	20,682	$389,822
Xarelto	Rivaroxaban	60	4,860	$87,597
Entresto	Sacubitril/Valsartan	52	2,605	$56,551
Farxiga	Dapagliflozin Propanediol	39	2,130	$36,695
Brilinta	Ticagrelor	18	1,260	$18,038

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$462	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for D. Gary Soya, M.D.?

Tedicare shows public-source Medicare data for D. Gary Soya, M.D. (NPI 1932175981), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does D. Gary Soya, M.D. have ACO affiliation data?

D. Gary Soya, M.D. is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to D. Gary Soya, M.D.?

D. Gary Soya, M.D. is linked to AMARILLO HEART INSTITUTE, LLP (billing NPI 1295448710) in the available physician profile data.

Does D. Gary Soya, M.D. have Open Payments data?

D. Gary Soya, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.